advertisement
9.4.5.5 Other (44)
Showing records 1 to 25
Display all abstracts in classification 9.4.5.5 Other
Search within classification 9.4.5.5 Other61701 Anti-VEGF therapy in the treatment of anterior segment neovascularization secondary to central retinal vein occlusion
Kabesha TB
Journal Français d'Ophtalmologie 2015; 38: 414-420
61739 Efficacy and Safety of Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema
Guigou S
Ophthalmologica 2015; 233: 169-175
61151 Bilateral Subretinal Fluid Mimicking Subretinal Neovascularization Within 24 Hours After Selective Laser Trabeculoplasty
Phillis CA
Journal of Glaucoma 2016; 25: e110-e114
61766 SUSTAINED ELEVATION OF INTRAOCULAR PRESSURE AFTER INTRAVITREAL ANTI-VEGF AGENTS: What Is the Evidence?
Dedania VS
Retina (Philadelphia, Pa.) 2015; 35: 841-858
61778 Decompression retinopathy after glaucoma surgery in children
Fadel AM
Journal of AAPOS 2015; 19: 286-289
61552 Laser treatment of macular retinoschisis due to acquired optic nerve pit from glaucoma
Prinzi RA
British Medical Journal (Clinical Research Edition) Case Reports 2015; 2015:
61545 Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study
Lam WC
Clinical Ophthalmology 2015; 9: 1255-1268
61544 Prevalence of comorbid retinal disease in patients with glaucoma at an academic medical center
Griffith JF
Clinical Ophthalmology 2015; 9: 1275-1284
61550 PERIPHERAL RETINAL DEGENERATIONS AND RHEGMATOGENOUS DETACHMENT IN PRIMARY CONGENITAL GLAUCOMA
Gupta S
Retina (Philadelphia, Pa.) 2016; 36: 188-191
61600 Posterior Subtenon's Capsule Triamcinolone Acetonide Injection for the Treatment of Diabetic Macular Edema
Ozkurt YB
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 455-460
61544 Prevalence of comorbid retinal disease in patients with glaucoma at an academic medical center
Goldberg JL
Clinical Ophthalmology 2015; 9: 1275-1284
61550 PERIPHERAL RETINAL DEGENERATIONS AND RHEGMATOGENOUS DETACHMENT IN PRIMARY CONGENITAL GLAUCOMA
Gogia V
Retina (Philadelphia, Pa.) 2016; 36: 188-191
61552 Laser treatment of macular retinoschisis due to acquired optic nerve pit from glaucoma
Desai A
British Medical Journal (Clinical Research Edition) Case Reports 2015; 2015:
61739 Efficacy and Safety of Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema
Pommier S
Ophthalmologica 2015; 233: 169-175
61701 Anti-VEGF therapy in the treatment of anterior segment neovascularization secondary to central retinal vein occlusion
Glacet-Bernard A
Journal Français d'Ophtalmologie 2015; 38: 414-420
61151 Bilateral Subretinal Fluid Mimicking Subretinal Neovascularization Within 24 Hours After Selective Laser Trabeculoplasty
Bourke RD
Journal of Glaucoma 2016; 25: e110-e114
61766 SUSTAINED ELEVATION OF INTRAOCULAR PRESSURE AFTER INTRAVITREAL ANTI-VEGF AGENTS: What Is the Evidence?
Bakri SJ
Retina (Philadelphia, Pa.) 2015; 35: 841-858
61778 Decompression retinopathy after glaucoma surgery in children
Bessa AS
Journal of AAPOS 2015; 19: 286-289
61545 Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study
Albiani DA
Clinical Ophthalmology 2015; 9: 1255-1268
61600 Posterior Subtenon's Capsule Triamcinolone Acetonide Injection for the Treatment of Diabetic Macular Edema
Akkaya S
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 455-460
61778 Decompression retinopathy after glaucoma surgery in children
Bayoumi NH
Journal of AAPOS 2015; 19: 286-289
61550 PERIPHERAL RETINAL DEGENERATIONS AND RHEGMATOGENOUS DETACHMENT IN PRIMARY CONGENITAL GLAUCOMA
Jose C
Retina (Philadelphia, Pa.) 2016; 36: 188-191
61739 Efficacy and Safety of Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema
Meyer F
Ophthalmologica 2015; 233: 169-175
61600 Posterior Subtenon's Capsule Triamcinolone Acetonide Injection for the Treatment of Diabetic Macular Edema
Aksoy S
Journal of Ocular Pharmacology and Therapeutics 2015; 31: 455-460
61545 Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study
Yoganathan P
Clinical Ophthalmology 2015; 9: 1255-1268